• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性血管内皮生长因子受体 1 促进狼疮肾炎患儿和青少年的血管内皮损伤。

Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis.

机构信息

Department of Pediatrics I, Innsbruck Medical University, Anichstr 35, 6020 Innsbruck, Austria.

出版信息

Pediatr Nephrol. 2012 May;27(5):793-800. doi: 10.1007/s00467-011-2062-z. Epub 2011 Dec 7.

DOI:10.1007/s00467-011-2062-z
PMID:22147121
Abstract

BACKGROUND

Endothelial cell injury plays a key role in the pathogenesis of lupus nephritis (LN) and atherosclerosis. The aim of this study was to identify factors involved in the process of endothelial damage in children and adolescents with LN.

METHODS

We evaluated the relationship between plasma vascular endothelial growth factor (VEGF), its soluble receptors sVEGFR-1 and sVEGFR-2 and markers of endothelial inflammation and injury (angiopoietin-2 and thrombomodulin, respectively) in 23 children and adolescents with LN (active LN, n = 14; inactive LN, n = 9; mean age 15 years) and 20 healthy controls (HC; mean age 12 years).

RESULTS

VEGF, sVEGFR-1, angiopoietin-2 and thrombomodulin levels were significantly higher in children and adolescents with active LN than in patients in remission or HC. In active LN, however, VEGF was inversely related to sVEGFR-1 (r = -0.802, p < 0.001), angiopoietin-2 (r = -0.684, p = 0.007) and thrombomodulin (r = -0.697, p = 0.006). There was a significant positive correlation between sVEGFR-1 and thrombomodulin (r = 0.814, p < 0.0001), but sVEGFR-2 did not significantly differ between the patient groups and did not correlate with thrombomodulin (r = 0.046, p = 0.833).

CONCLUSIONS

sVEGFR-1 may play an important role in promoting endothelial damage in children and adolescents with active LN and could possibly be used to monitor disease severity.

摘要

背景

内皮细胞损伤在狼疮肾炎 (LN) 和动脉粥样硬化的发病机制中起关键作用。本研究旨在确定与 LN 患儿内皮损伤过程相关的因素。

方法

我们评估了 23 例 LN 患儿(活动期 LN,n=14;缓解期 LN,n=9;平均年龄 15 岁)和 20 例健康对照者(HC;平均年龄 12 岁)的血浆血管内皮生长因子 (VEGF)、其可溶性受体 sVEGFR-1 和 sVEGFR-2 与内皮炎症和损伤标志物(分别为血管生成素-2 和血栓调节蛋白)之间的关系。

结果

活动期 LN 患儿的 VEGF、sVEGFR-1、血管生成素-2 和血栓调节蛋白水平明显高于缓解期患儿和 HC。然而,在活动期 LN 中,VEGF 与 sVEGFR-1(r=-0.802,p<0.001)、血管生成素-2(r=-0.684,p=0.007)和血栓调节蛋白(r=-0.697,p=0.006)呈负相关。sVEGFR-1 与血栓调节蛋白呈显著正相关(r=0.814,p<0.0001),但 sVEGFR-2 在各组间无明显差异,与血栓调节蛋白无相关性(r=0.046,p=0.833)。

结论

sVEGFR-1 可能在促进活动期 LN 患儿内皮损伤中起重要作用,可能用于监测疾病严重程度。

相似文献

1
Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis.可溶性血管内皮生长因子受体 1 促进狼疮肾炎患儿和青少年的血管内皮损伤。
Pediatr Nephrol. 2012 May;27(5):793-800. doi: 10.1007/s00467-011-2062-z. Epub 2011 Dec 7.
2
Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.系统性红斑狼疮患者血清中的血管内皮生长因子及其可溶性受体VEGFR - 1和VEGFR - 2
Mediators Inflamm. 2003 Oct;12(5):293-8. doi: 10.1080/09629350310001619726.
3
Biomarkers associating endothelial Dysregulation in pediatric-onset systemic lupus erythematous.与儿童起病系统性红斑狼疮内皮失调相关的生物标志物。
Pediatr Rheumatol Online J. 2019 Oct 24;17(1):69. doi: 10.1186/s12969-019-0369-7.
4
Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.循环血管内皮生长因子 (VEGF) 及其可溶性受体 1 (sVEGFR-1) 与新发生透析患者的炎症和死亡率相关。
Nephrol Dial Transplant. 2013 Sep;28(9):2356-63. doi: 10.1093/ndt/gft256. Epub 2013 Jul 4.
5
Serum syndecan-1, hyaluronan and thrombomodulin levels in patients with lupus nephritis.狼疮肾炎患者血清 syndecan-1、透明质酸和血栓调节蛋白水平。
Rheumatology (Oxford). 2021 Feb 1;60(2):737-750. doi: 10.1093/rheumatology/keaa370.
6
Circulating thrombomodulin and vascular cell adhesion molecule-1 and renal vascular lesion in patients with lupus nephritis.狼疮性肾炎患者循环中的血栓调节蛋白、血管细胞黏附分子-1与肾血管病变
Lupus. 2008 Aug;17(8):720-6. doi: 10.1177/0961203308089441.
7
Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.可溶性 TNF-R1、VEGF 和其他细胞因子作为系统性红斑狼疮和狼疮性肾炎疾病活动的标志物。
Lupus. 2019 May;28(6):713-721. doi: 10.1177/0961203319845487. Epub 2019 May 2.
8
Soluble Flt-1, Placental Growth Factor, and Vascular Endothelial Growth Factor Serum Levels to Differentiate Between Active Lupus Nephritis During Pregnancy and Preeclampsia.可溶性Flt-1、胎盘生长因子和血管内皮生长因子血清水平用于鉴别妊娠期活动性狼疮性肾炎和先兆子痫。
Arthritis Care Res (Hoboken). 2021 May;73(5):717-721. doi: 10.1002/acr.24360. Epub 2021 Apr 3.
9
Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.急性白血病患者循环中的血管内皮生长因子(VEGF)及其可溶性受体sVEGFR - 1和sVEGFR - 2 。
Eur Cytokine Netw. 2003 Jul-Sep;14(3):149-53.
10
Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.血管生成素-2、内皮功能障碍与系统性红斑狼疮患者的肾脏受累。
J Nephrol. 2012 Jul-Aug;25(4):541-50. doi: 10.5301/jn.5000030.

引用本文的文献

1
Serum and urinary biomarkers in lupus nephritis: do suPAR and VEGF play a role?狼疮性肾炎中的血清和尿液生物标志物:可溶性尿激酶型纤溶酶原激活物受体(suPAR)和血管内皮生长因子(VEGF)发挥作用吗?
J Bras Nefrol. 2025 Oct-Dec;47(4):e20240137. doi: 10.1590/2175-8239-JBN-2024-0137en.
2
Lactobacillus plantarum CQPC02 intervenes in mouse lupus nephritis by regulating the NF-κB signaling pathway.植物乳杆菌 CQPC02 通过调控 NF-κB 信号通路干预狼疮肾炎小鼠模型。
Braz J Microbiol. 2023 Sep;54(3):2093-2102. doi: 10.1007/s42770-023-01072-5. Epub 2023 Aug 1.
3
The Inflammatory Profile Orchestrated by Inducible Nitric Oxide Synthase in Systemic Lupus Erythematosus.

本文引用的文献

1
Early determinants of atherosclerosis in paediatric systemic lupus erythematosus.儿科系统性红斑狼疮中动脉粥样硬化的早期决定因素。
Clin Exp Rheumatol. 2011 May-Jun;29(3):575-81. Epub 2011 Jun 30.
2
Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.系统性红斑狼疮与心血管疾病:预测及治疗干预的可能性。
Expert Rev Clin Immunol. 2011 Mar;7(2):227-41. doi: 10.1586/eci.10.98.
3
The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.系统性红斑狼疮中炎症与心血管疾病的相互作用。
诱导型一氧化氮合酶在系统性红斑狼疮中所调控的炎症谱
J Pers Med. 2023 May 31;13(6):934. doi: 10.3390/jpm13060934.
4
Subclinical signs of podocyte injury associated with Circulating Anodic Antigen (CAA) in Schistosoma mansoni-infected patients in Brazil.巴西曼氏血吸虫感染患者循环阳极抗原(CAA)相关足细胞损伤的亚临床征象。
Rev Soc Bras Med Trop. 2023 Feb 20;56:e0341. doi: 10.1590/0037-8682-0341-2022. eCollection 2023.
5
Effects of HFY15 on Lupus Nephritis in Mice by Regulation of the TGF-β1 Signaling Pathway.HFY15 通过调控 TGF-β1 信号通路对狼疮肾炎小鼠的作用。
Drug Des Devel Ther. 2022 Aug 26;16:2851-2860. doi: 10.2147/DDDT.S363974. eCollection 2022.
6
Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.循环血栓调节蛋白:释放机制、检测方法以及在疾病和医疗程序中的水平
TH Open. 2022 Jul 11;6(3):e194-e212. doi: 10.1055/a-1801-2055. eCollection 2022 Jul.
7
Association of Circulating Vascular Endothelial Growth Factor Levels With Autoimmune Diseases: A Systematic Review and Meta-Analysis.循环血管内皮生长因子水平与自身免疫性疾病的关联:系统评价和荟萃分析。
Front Immunol. 2021 May 27;12:674343. doi: 10.3389/fimmu.2021.674343. eCollection 2021.
8
Gene polymorphisms and serum levels of sVEGFR-1 in patients with systemic lupus erythematosus.系统性红斑狼疮患者的基因多态性与 sVEGFR-1 血清水平。
Sci Rep. 2020 Sep 14;10(1):15031. doi: 10.1038/s41598-020-72020-8.
9
Urinary biomarkers in lupus nephritis.狼疮性肾炎中的尿液生物标志物
J Transl Autoimmun. 2020 Feb 13;3:100042. doi: 10.1016/j.jtauto.2020.100042. eCollection 2020.
10
Meta-analysis of associations of vascular endothelial growth factor protein levels and -634G/C polymorphism with systemic lupus erythematosus susceptibility.血管内皮生长因子蛋白水平与-634G/C 多态性与系统性红斑狼疮易感性的关联的荟萃分析。
BMC Med Genet. 2019 Mar 22;20(1):46. doi: 10.1186/s12881-019-0783-1.
Arthritis Res Ther. 2011 Feb 28;13(1):203. doi: 10.1186/ar3264.
4
The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?内皮细胞:系统性红斑狼疮中自身免疫与动脉粥样硬化的界面?
Lupus. 2011 Jan;20(1):5-13. doi: 10.1177/0961203310382429. Epub 2010 Dec 7.
5
Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.可溶性 VEGFR-2:VEGF 受体的抗淋巴管生成变体。
Ann N Y Acad Sci. 2010 Oct;1207 Suppl 1(Suppl 1):E7-15. doi: 10.1111/j.1749-6632.2010.05714.x.
6
Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment.可溶性血管内皮生长因子受体-1 和 -2 通过募集壁细胞促进血管成熟。
FASEB J. 2010 Oct;24(10):3782-95. doi: 10.1096/fj.09-149070. Epub 2010 May 19.
7
Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients.血管内皮生长因子及其受体 sVEGFR-1 和 -2 与维持性血液透析患者心血管疾病及生存的相关性。
Nephrol Dial Transplant. 2009 Nov;24(11):3468-73. doi: 10.1093/ndt/gfp315. Epub 2009 Jun 26.
8
Vascular endothelial growth factor as a prognostic marker of lupus nephritis.血管内皮生长因子作为狼疮性肾炎的预后标志物。
Kidney Int. 2009 Jun;75(12):1251-1253. doi: 10.1038/ki.2009.101.
9
Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus.系统性红斑狼疮患者过早动脉粥样硬化的纵向研究。
Atherosclerosis. 2009 Oct;206(2):546-50. doi: 10.1016/j.atherosclerosis.2009.03.018. Epub 2009 Mar 25.
10
Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis.狼疮性肾炎中血管内皮生长因子的肾脏表达降低与较差的预后相关。
Kidney Int. 2009 Jun;75(12):1340-1348. doi: 10.1038/ki.2009.75. Epub 2009 Mar 18.